{"subsection_name": null, "pub_date": "2011-10-04T00:00:00Z", "byline": {"original": "By PAM BELLUCK", "contributor": "", "person": [{"lastname": "BELLUCK", "organization": "", "rank": 1, "role": "reported", "firstname": "Pam"}]}, "abstract": null, "word_count": "1273", "print_page": "1", "news_desk": "Foreign", "snippet": "A new study suggests that an injectable, hormonal contraceptive popular with African women has biological properties that may make women and men more vulnerable to H.I.V. infection.", "multimedia": [], "source": "The New York Times", "blog": [], "keywords": [{"name": "glocations", "is_major": "N", "value": "Africa", "rank": "1"}, {"name": "subject", "is_major": "N", "value": "Acquired Immune Deficiency Syndrome", "rank": "2"}, {"name": "subject", "is_major": "N", "value": "Birth Control and Family Planning", "rank": "3"}], "type_of_material": "News", "lead_paragraph": "A new study suggests that an injectable, hormonal contraceptive popular with African women has biological properties that may make women and men more vulnerable to H.I.V. infection.", "web_url": "http://www.nytimes.com/2011/10/04/health/04hiv.html", "section_name": "Health", "headline": {"main": "Contraceptive Used in Africa May Double Risk of H.I.V.", "print_headline": "Contraceptive Said to Double Risks of H.I.V.", "seo": "Contraceptive Used in Africa May Double Risk of H.I.V."}, "slideshow_credits": null, "_id": "5401b62738f0d841b2f3a042", "document_type": "article"}